HISTORY: A 20 year old sophomore collegiate wrestler, with known lumbar degenerative disk disease (DDD) since high school, presented with worsening back pain and bilateral proximal anterior thigh pain. An MRI done 5 months prior to presentation had shown moderate degenerative changes at several lumbar levels, with disk height and disk desiccation. There was also an L5-S1 annulus tear with disk protrusion. He had undergone relative rest, therapeutic exercises, two lumbar trigger point injections, and two epidural steroid injections (ESI) at the L5-S1level in the interim, with the most recent ESI done three weeks prior to presentation. His back pain had initially been much better after each ESI, with symptoms acutely worsening as above. He had been able to gain some weight through exercise and denied any systemic symptoms (e.g., fever, chills), although he had symptoms of a mild upper respiratory tract infection on presentation. PHYSICAL EXAMINATION: Examination in clinic showed normal vital signs. The patient had an antalgic, guarded gait, with marked restriction of lumbar flexion to due pain. There was no tenderness to palpation. Straight leg raise bilaterally was negative, and his leg neurologic exam was normal. DIFFERENTIAL DIAGNOSIS: Acute lumbar disk herniation Acute exacerbation of lumbar DDD Lumbar strain Infectious spinal process TEST AND RESULTS: MRI lumbar spine: Diffuse annular bulging with L5-S1 central disk protrusion Normal vertebral height Markedly narrowed L3-4 disk L4 superior endplate destruction Osseous edema in L3, L4 bodies, extending in to psoas adjacent to disk Labs: Aspiration of L3, L4: Few methicilliin resistant Staphylococcus aureus (MRSA) Blood cultures (2 sites): no growth Complete blood count: normal white blood cell count, hemoglobin, hematocrit, and platelets Sedimentation rate: elevated at 45 C-reactive protein: normal FINAL WORKING DIAGNOSIS: MRSA Osteomyelitis/diskitis of L3-4, likely related to epidural steroid injection for DDD TREATMENT AND OUTCOMES: Vancomycin was administered through a central line every 12 hours for 4 weeks. After Vancomycin treatment ended, the patient took sulfamethoxazole/trimethoprim, orally, every 12 hours for 4 weeks. Three months after diagnosis, he started cardiovascular exercises and light wrestling drills.
Read full abstract